T1	Participants 78 310	A multicenter, double-blind, between-patient trial comparing two doses of ketazolam (15 and 30 mg) with placebo, each given once daily, in the evening, to 92 outpatients affected by generalized anxiety disorders for at least 1 month
T2	Participants 357 368	47 patients
T3	Participants 854 876	Seventy-eight patients
